Sun Pharma, Caraco plan to file 30 patent pleas for generics

17 Sep 2009 Evaluate

Sun Pharmaceutical Industries and its troubled US subsidiary, Caraco Pharmaceuticals, plan to together file 30 Abbreviated New Drug Applications with the US Food and Drug Administration (FDA) to market generic drugs, despite regulatory issues for the US company.

 

Between Sun and Caraco, 111 products are pending for approval with the USFDA at the end of June 2009. Caraco is working with the USFDA to resolve all the problems as soon as possible. Factories in Sun Pharma remained fully complaint with USFDA and current good manufacturing practices (cGMP) requirements.

 

In June 2009, US marshals had raided Caraco's manufacturing facilities in the state of Michigan, at Detroit, Farmington Hills, and Wixom. Up to 33 different drugs were seized by the US marshals and the FDA banned Caraco from manufacturing and selling these drugs in the US, until there was assurance that the firm complies with manufacturing standards. The action came after Caraco's continued failure to meet the FDA's cGMP requirements.crackcrack

Sun Pharma Inds. Share Price

1717.50 -1.70 (-0.10%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×